From 5 to 11 October 2026, a week-long forum billed as the Nobel Heroes Day – AI For Science Summit (AFSS) will bring together Nobel laureates, scientists, leaders in artificial intelligence, government figures, universities and patient capital in Singapore to examine how machine learning can accelerate scientific discovery and its application.
Summit aims and structure
Co‑hosted by Laureates City Holdings Limited and Symbiosis Science, the event is organised around the theme “Science • Intelligence • Capital”. The stated ambition is to create a global platform that more closely links breakthrough research, frontier AI technologies and long‑term investment to speed the movement of discoveries into productive use.
The programme, as described by the organisers, will include a two‑day flagship forum, an invitation‑only Gala Dinner, a series of closed‑door leadership roundtables and a week‑long public exhibition showcasing Nobel laureate portraits at Singapore’s Gardens by the Bay.
“Scientific discovery no longer happens in isolation,” the organisers said.
Who is taking part
The summit has confirmed participation from Nobel laureates including Sir Christopher Pissarides (Nobel Prize in Economic Sciences, 2010) and Professor Benjamin List (Nobel Prize in Chemistry, 2021). Beyond laureates, the invitation list is said to extend to AI pioneers, government leaders, academic institutions and investors focused on patient, long‑term capital.
Organisers argue that as artificial intelligence reshapes research — from drug discovery and advanced materials to life sciences and climate technologies — breakthroughs will increasingly arise at the intersection of disciplines and sectors.
Why Singapore?
Singapore was chosen as host because of its internationally connected research ecosystem, a position described as neutral for global collaboration, and a strong environment for innovation. The summit is positioned as a neutral meeting point where scientific, technological and financial actors can pursue partnerships and pathways to implementation.
Programme at a glance
| Dates | Featured formats | Venue |
|---|---|---|
| 5–11 October 2026 | Flagship forum, Gala Dinner, leadership roundtables, public exhibition | Singapore (including Gardens by the Bay) |
- Confirmed Nobel laureates: Sir Christopher Pissarides; Professor Benjamin List.
- Main theme: Science • Intelligence • Capital — bridging research, AI and investment.
- Public element: Nobel laureate portrait exhibition over the week.
Context and consequences
The AFSS is part of a broader push to apply AI not simply as a tool for data analysis, but as a driver of discovery — automating parts of experimental design, optimising materials and accelerating candidate selection in fields such as pharmaceuticals and materials science. The organisers frame the summit as an effort to align the early stages of research with the incentives and risk profiles of long‑term investors, thereby shortening the route from laboratory result to scalable application.
That alignment is not trivial. Translating algorithmic advances into validated, regulated and manufacturable products requires sustained investment, regulatory engagement and cross‑disciplinary collaboration. By convening scientists, investors and policy figures, the summit aims to surface practical pathways and potential funding models to support such translation. The extent to which these conversations produce measurable pipelines of funded projects or new public‑private initiatives will determine the summit’s longer‑term impact.
For the UK and other research nations, forums of this type can serve two functions: they act as marketplaces for collaboration and capital, and they spotlight strategic priorities where public policy and funding could either accelerate or constrain adoption. With Nobel laureates present, sponsors and delegates will be keen to convert high‑level dialogue into concrete commitments — research partnerships, trial funding, or co‑ordinated investment vehicles — though the organisers have not published any pledges or funding totals ahead of the event.
As the AFSS approaches, attention will fall on the summit’s ability to move beyond statements of intent to demonstrable pipelines that couple AI innovation with the long horizons and patient capital often required in deep science.
